$0.38
-0.30 (-44.66%)
Open$0.40
Previous Close$0.68
Day High$0.42
Day Low$0.31
52W High$32.22
52W Low$16.66
Volume—
Avg Volume257.0K
Market Cap2.96M
P/E Ratio34.35
EPS$0.71
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
+8,077.0% upside
Current
$0.38
$0.38
Target
$30.77
$30.77
$21.48
$30.77 avg
$35.71
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 724.3K | 759.7K | 723.6K |
| Net Income | -22,347 | -24,634 | -22,962 |
| Profit Margin | -3.1% | -3.2% | -3.2% |
| EBITDA | -36,678 | -38,889 | -37,851 |
| Free Cash Flow | -27,891 | -29,815 | -29,431 |
| Rev Growth | -7.8% | +6.1% | +6.1% |
| Debt/Equity | 0.62 | 0.67 | 0.52 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |